TAIPEI, July 24, 2025 -- As digital transformation deepens across industries, enterprises increasingly demand visualization and system integration of information. CAYIN Technology announces SMP digital signage player with enhanced integration capabilities, widely applicable across manufacturing, healthcare, government, transportation, and other sectors—becoming a core platform for operational information delivery and decision support. Manufacturing Sector: Integrating ERP/MES Systems to Achieve Smart Production Transparency The SMP player supports API data streaming and
[ 메디채널 김갑성 기자 ] 상하이 2025년 7월 24일 -- 전 세계 구강 건강 전문가를 위한 세계 최고의 행사 중 하나인 FDI 세계치과총회(FDI World Dental Congress, WDC)가 2025년 9월 9일부터 12일까지 중국 상하이에서 열린다. 이번 총회는 중화구강의학회(Chinese Stomatological Association)와 리드 시노팜 전시(Reed Sinopharm Exhibitions)가 공동 주최한다. 매년 다른 국가에서 개최되는 WDC는 전반적인 건강과 웰빙을 보장하는 데 있어 구강 건강의 중요성을 강조하고, 치의학 분야의 국제 협력을 위한 원동력으로 자리 잡고 있다. 최근 몇 년간 비자 면제 정책 덕분에 중국은 전 세계 여행객에게 더욱 인기 있는 여행지가 됐다. 이러한 접근성 향상, 글로벌 도시로서 상하이가 가진 매력과 선도적인 글로벌 치과 행사라는 FDI의 위상이 더해져 2025년 행사에서 이미 1만 명 이상의 총회 대표를 유치했다. 주최측은 134개 국가 및 지역에서 3만 5000명 이상의 전문 참석자와 방문객이 방문할 것으로 예측하고 있다. 이번 총회에서는 300명이
With the launch of PFPFA (Malaysia), SingWealth Holdings deepens its regional presence and strengthens its commitment to delivering trusted, client-centric financial advisory solutions across Singapore, Malaysia, and Hong Kong SAR. SINGAPORE, July 24, 2025 -- SingWealth Holdings today announced the official launch of PFPFA (Malaysia) Sdn. Bhd. ("PFPFA Malaysia"), furthering the Group's commitment to delivering integrated financial advisory solutions across Asia. The launch ceremony, held yesterday at the Grand Hyatt Kuala Lumpur, brought together key st
HONG KONG, July 24, 2025 -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a first-in-class PD-1/VEGF bispecific antibody developed by the company. The trial is investigating ivonescimab in combination with chemotherapy, with or without ligufalimab (CD47 monoclonal antibody), for the first-line treatment of metastatic pancreatic cancer. Pancreatic cancer remains one of the most challenging types of tumors to f
[ 메디채널 김갑성 기자 ] Ahead of the upcoming UN General Assembly to set a new vision for non-communicable diseases, the Global Self-Care Federation is calling for self-care strategies to be integrated into health plans Non-communicable diseases account for 76% of global deaths, and their impact continues to rise[1] Current self-care activities are generating substantial global monetary savings ($119 billion per year) as well as healthcare workforce savings – with huge potential to unlock further savings[2] GENEVA, July 24, 2025 -- On International Self-Care Day, and as world leaders p
LEHI, Utah, July 24, 2025 -- Amare Global, The Mental Wellness Company™, is pleased to announce a powerful new chapter; effective immediately, David Chung, Owner and Chairman of Amare Global, will assume the role of Chief Executive Officer. With an unmatched passion for Amare's mission and a relentless drive to see every brand partner succeed, Chung is stepping into this role to lead Brand Partners into the most exciting and expansive era in Amare history. "We are grateful for Asma Ishaq's leadership and wish her continued success," said Chung of Amare's former CEO. Am
Independent audit confirms TraceLink's operational rigor and readiness to meet evolving customer and regulatory demands BOSTON, July 23, 2025 -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced the successful completion of its ISO 9001:2015 annual surveillance audit, expanding scope to include OPUS, the Orchestration Platform for Universal Solutions. The achievement reaffirms the company's commitment to delivering high-quality, reliable, and continuously-improving solutions and platform capabilities for organ
CHENGDU, China, July 23, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", HKEX: 6990) today announced that its partner, Windward Bio AG ("Windward Bio") has launched its Phase 2 POLARIS clinical study, assessing long-acting dosing of SKB378/WIN378 for people living with asthma. SKB378/WIN378 is a novel, recombinant fully human monoclonal antibody (mAb) that potently binds to the thymic stromal lymphopoietin (TSLP) ligand and inhibits the TSLP mediated signaling pathway by blocking the intera
STUART, Fla., July 23, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce it will host an exclusive half-day Summit on January 20, 2026, from 11:30 a.m. to 4:30 p.m. (CET) at the prestigious Belvedere Hotel in Davos, Switzerland, alongside the week of the World Economic Forum (WEF) Annual Meeting. The World Economic Forum, held each January in Davos, is one of the world's most prestigious gatherings of global leaders from business, government, academia, and civil society. It serves as a un
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31 Unifying global diagnostic data - STAgora™, the big data platform set to transform the future of diagnostics Pilot partnerships to offer early access to the new diagnostic paradigm, with selected institutions engaged by year-end SEOUL, South Korea, July 23, 2025 -- Seegene Inc., a global leader in molecular diagnostics, announced today that it will unveil its fully automated PCR testing system, CURECA™, and its data analytics platform, STAgora™